MedPath

PRO-APIXABAN

PRO-APIXABAN

Approved
DIN Number

02530732

Drug Class

Human

Market Date

Sep 26, 2022

Company
HC

PRO DOC LIMITEE

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02530732
AIG Number0153051002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AF02 APIXABAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.04.14
Health Canada Classification

ACTIVE INGREDIENTS (1)

APIXABANActive
Strength: 5 MG
Monograph: APIXABAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.